Dr. Charles J. Ryan is the Clinical Program Leader for Genitourinary Medical Oncology at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center.
He primarily treats men with advanced prostate cancer. His research focuses on novel therapies for advanced prostate cancer.
Why did you become a doctor?
Dr. Ryan: I grew up in a medium-sized city called Appleton, Wisconsin. My father was the first medical oncologist and the first prescriber of chemotherapy in our town. He never did a fellowship because they didn’t exist when he finished his training.
I’m the youngest of four kids. By the time I was in junior high school, all of my siblings had gone away. My mother is a nurse, and she was working for hospice in our community. Sitting around the dinner table, it was just the three of us.
The dinner conversation was frequently about cancer, hospice, medicine, and things like that. That’s what shaped me at the time. I decided to become a physician in college, but I had given a lot of thought to oncology and medicine well before making the decision.
I guess medicine is the family business?
Dr. Ryan: Yes. It is sort of a family business. When I started my medical training, I felt a kinship with the medical oncologists I interacted with at the University of Wisconsin. I was randomly assigned to work in an oncology clinic and a prostate cancer clinic. I just felt like: these are my people. The timing was right for me to make a decision. It’s what I wanted to do with my life. I found the disease itself biologically compelling, and the emergence of new therapies and the community of physicians and researchers who worked on it were an interesting group of people. It was a natural decision.